Cidel Asset Management Inc. trimmed its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 14.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 81,786 shares of the company’s stock after selling 13,326 shares during the quarter. Cidel Asset Management Inc.’s holdings in Procter & Gamble were worth $11,882,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Summit Global Investments boosted its holdings in shares of Procter & Gamble by 47.5% in the third quarter. Summit Global Investments now owns 20,089 shares of the company’s stock valued at $2,919,000 after buying an additional 6,472 shares during the period. Sagace Wealth Management LLC raised its holdings in shares of Procter & Gamble by 12.8% during the third quarter. Sagace Wealth Management LLC now owns 2,039 shares of the company’s stock worth $296,000 after acquiring an additional 232 shares during the period. Americana Partners LLC lifted its position in Procter & Gamble by 4.5% in the 3rd quarter. Americana Partners LLC now owns 80,071 shares of the company’s stock valued at $11,633,000 after acquiring an additional 3,412 shares in the last quarter. Fusion Capital LLC lifted its position in Procter & Gamble by 9.4% in the 3rd quarter. Fusion Capital LLC now owns 2,056 shares of the company’s stock valued at $299,000 after acquiring an additional 177 shares in the last quarter. Finally, State of Wyoming acquired a new position in Procter & Gamble in the 3rd quarter worth $87,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Key Headlines Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Analyst upgrade: Freedom Broker upgraded PG from “hold” to “buy,” providing a positive signal for the stock and reflecting greater confidence in the company’s outlook. Freedom Broker upgrades Procter & Gamble to buy from hold
- Positive Sentiment: Dividend appeal remains strong: Articles highlighted PG as a long-standing dividend leader, supporting its appeal to income-focused and defensive investors. The company’s record of dividend increases may help underpin demand for the shares, particularly when investors favor stable consumer-staples businesses. Dividend Kings article Trusted dividend stocks article
- Neutral Sentiment: Bond issuance adds balance-sheet context: PG’s euro- and dollar-denominated bond sale provides liquidity and funding flexibility, but it also draws attention to leverage, interest costs, and the company’s relatively elevated valuation. Procter & Gamble bond sale
- Neutral Sentiment: Growth story under review: Commentary on PG points to accelerating revenue growth, while also noting that higher operating costs could pressure margins and earnings. Investors are weighing improved sales momentum against cost inflation. Procter & Gamble revenue growth and costs What changed in Procter & Gamble’s story
- Negative Sentiment: Mixed rating signals and valuation risk: DZ Bank downgraded PG from “strong-buy” to “hold.” With shares trading at a premium valuation, a more cautious analyst stance could weigh on upside unless earnings growth accelerates. DZ Bank rating change
- Negative Sentiment: Advertising challenge produced only a limited win: Following PG’s challenge, the National Advertising Division supported Carpe’s $19.95 reference price but recommended changes or removal of other savings, free-shipping, comparative-performance, and “first” 100-hour protection claims. The outcome may modestly strengthen competitive advertising standards, but it does not represent a material financial catalyst for PG. National Advertising Division decision involving Carpe
Procter & Gamble Trading Up 0.5%
Shares of NYSE:PG opened at $161.42 on Friday. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $167.25. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.53 and a current ratio of 0.72. The company has a market capitalization of $374.14 billion, a P/E ratio of 24.31, a price-to-earnings-growth ratio of 3.97 and a beta of 0.39. The company has a 50-day simple moving average of $149.99 and a 200 day simple moving average of $148.94.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, topping analysts’ consensus estimates of $1.89 by $0.11. The firm had revenue of $23.28 billion for the quarter, compared to the consensus estimate of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The business’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.99 earnings per share. Sell-side analysts forecast that Procter & Gamble Company will post 6.99 earnings per share for the current year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be paid a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s payout ratio is currently 65.51%.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on PG shares. Bank of America decreased their price objective on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a report on Friday, July 10th. Freedom Broker upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $176.00 target price on the stock in a research note on Friday, October 23rd. BNP Paribas Exane upped their price target on Procter & Gamble from $177.00 to $189.00 and gave the stock an “outperform” rating in a research report on Friday, October 23rd. Wells Fargo & Company raised their price target on shares of Procter & Gamble from $164.00 to $180.00 and gave the stock an “overweight” rating in a research note on Friday, October 23rd. Finally, DZ Bank cut Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 27th. Fifteen research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $170.57.
View Our Latest Stock Analysis on Procter & Gamble
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO Paul Gama sold 4,331 shares of the firm’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $161.27, for a total transaction of $698,460.37. Following the completion of the sale, the chief executive officer owned 46,793 shares of the company’s stock, valued at $7,546,307.11. This trade represents a 8.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Andre Schulten sold 3,914 shares of Procter & Gamble stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the transaction, the chief financial officer directly owned 65,618 shares of the company’s stock, valued at approximately $9,536,920.12. This trade represents a 5.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 58,647 shares of company stock worth $9,268,508 in the last three months. 0.23% of the stock is owned by company insiders.
About Procter & Gamble
Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
